Trovis Pharmaceuticals, LLC
Records under this name other than patents Trovis Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Trovis Pharmaceuticals, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,258,142 | Substituted 8-[6-Amino-3-Pyridyl]XANTHINES now held by Allergan Sales, LLC In force · High confidence | In force | High confidence | |
| US 7,598,379 | Methods for the Synthesis of Unsymmetrical Cycloalkyl Substituted Xanthines now held by Allergan Sales, LLC In force · High confidence | In force | High confidence | |
| US 7,342,006 | Substituted 8-Heteroaryl Xanthines now held by Allergan Sales, LLC Term ended Term ended Nov 7, 2025 · High confidence | Term ended | Term ended Nov 7, 2025 | High confidence |
| US 8,420,813 | Methods for the Synthesis of Unsymmetrical Cycloalkyl Substituted Xanthines now held by Allergan Sales, LLC Lapsed on the fee record Ended Apr 16, 2025 · High confidence | Lapsed on the fee record | Ended Apr 16, 2025 | High confidence |
| US 7,732,455 | Substituted 8-Heteroaryl Xanthines now held by Allergan Sales, LLC Term ended Term ended Aug 20, 2024 · High confidence | Term ended | Term ended Aug 20, 2024 | High confidence |
| US 7,884,100 | Substituted 8-[6-Amino-3-Pyridyl]XANTHINES now held by Allergan Sales, LLC Lapsed on the fee record Ended Feb 8, 2023 · High confidence | Lapsed on the fee record | Ended Feb 8, 2023 | High confidence |
| US 8,551,972 | Agonists of A2A Adenosine Receptors for Treating Recurrent Tumor Growth now held by Adenosine Therapeutics, LLC Lapsed on the fee record Ended Oct 8, 2021 · High confidence | Lapsed on the fee record | Ended Oct 8, 2021 | High confidence |
| US 7,875,608 | Substituted 8-[6-Amino-3PYRIDYL]XANTHINES now held by Adenosine Therapeutics, LLC Lapsed on the fee record Ended Jan 25, 2019 · High confidence | Lapsed on the fee record | Ended Jan 25, 2019 | High confidence |
| US 7,671,191 | Methods for Preparing 2-Alkynyladenosine Deriviatives now held by Adenosine Therapeutics, LLC Lapsed on the fee record Ended Mar 2, 2018 · Medium confidence | Lapsed on the fee record | Ended Mar 2, 2018 | Medium confidence |
| US 8,349,848 | Pyrrolo[3,2-d]pyrimidines That Are Selective Antagonists of A2B Adenosine Receptors now held by Adenosine Therapeutics, LLC Lapsed on the fee record Ended Jan 8, 2017 · High confidence | Lapsed on the fee record | Ended Jan 8, 2017 | High confidence |